In clinical practice, breast cancer tumors can be mainly classified into three molecular subtypes: estrogen receptor (ER) positive, human epidermal growth factor receptor 2 (HER2)-positive, and triple-negative [2]. This evidence concerns the gene ERBB2 and breast carcinoma.